Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer-Reference-Cited by-同舟云学术

Staging Paradox and Discrepancy in Adjuvant Chemotherapy in Patients with T4N0, T1-2N1, and T3N1 Colon Cancer

Published:2021-02-04 Issue:5 Volume:45 Page:1561-1568
ISSN:0364-2313
Container-title:World Journal of Surgery
language:en
Short-container-title:World J Surg

Author:

Shimizu Hiroki^ORCID,Kuriu Yoshiaki,Arita Tomohiro,Kiuchi Jun,Yamamoto Yusuke,Konishi Hirotaka,Morimura Ryo,Shiozaki Atsushi,Ikoma Hisashi,Kubota Takeshi,Fujiwara Hitoshi,Okamoto Kazuma,Otsuji Eigo

Publisher

Springer Science and Business Media LLC

Subject

Surgery

Link

http://link.springer.com/content/pdf/10.1007/s00268-021-05973-0.pdf

Reference22 articles.

1. Brierley JD, Gospodarowicz M, Wittekind C (2017) TNM classification of malignant tumours UICC. Wiley Blackwell, New Jersey

2. Kim MJ, Jeong SY, Choi SJ et al (2015) Survival paradox between stage IIB/C (T4N0) and stage IIIA (T1–2N1) colon cancer. Ann Surg Oncol 22:505–512

3. Chu QD, Zhou M, Medeiros KL et al (2016) Poor survival in stage IIB/C (T4N0) compared to stage IIIA (T1–2 N1, T1N2a) colon cancer persists even after adjusting for adequate lymph nodes retrieved and receipt of adjuvant chemotherapy. BMC cancer 16:460

4. Kim HS, Kim KM, Lee SB et al (2019) Clinicopathological and biomolecular characteristics of stage IIB/IIC and stage IIIA colon cancer: insight into the survival paradox. J Surg Oncol 120:423–430

5. Rottoli M, Stocchi L, Dietz DW (2012) T4N0 colon cancer has oncologic outcomes comparable to stage III in a specialized center. Ann Surg Oncol 19:2500–2505

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Causes Behind the Survival Paradox in Non-Metastatic Colorectal Cancer Patients and its Impact on the Treatment Regimen: A Retrospective Cohort Study;Surgery;2024-08

2. Value of the Tumor-Stroma Ratio and Structural Heterogeneity Measured by a Novel Semiautomatic Image Analysis Technique for Predicting Survival in Patients With Colon Cancer;Diseases of the Colon & Rectum;2022-12-15

3. Minimally Invasive Surgery for Colorectal Cancer During the COVID-19 Pandemic in a Tertiary Medical Facility in Japan;In Vivo;2022